זומרה ® 4 מ"ג/5 מ"ל

Pays: Israël

Langue: hébreu

Source: Ministry of Health

Ingrédients actifs:

ZOLEDRONIC ACID 4 MG/VIAL

Disponible depuis:

NOVARTIS PHARMA SERVICES AG

Code ATC:

M05BA08

forme pharmaceutique:

CONCENTRATE FOR SOLUTION FOR INFUSION

Mode d'administration:

I.V

Fabriqué par:

NOVARTIS PHARMA STEIN AG, SWITZERLAND

Groupe thérapeutique:

ZOLEDRONIC ACID

indications thérapeutiques:

Treatment of hypercalcaemia of malignancy. Treatment of patients with multiple myeloma and patients with documented bone metastases from solid tumors , in conjunction with standard antineoplastic therapy. Prostate cancer should have progressed after treatment with at least one hormonal therapy.

Date de l'autorisation:

2013-11-01